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Enhanced Retention in the Passive-Avoidance
Task By 5-HT1A Receptor Blockade
Is Not Associated With Increased Activity
of the Central Nucleus of the Amygdala
Allen M. Schneider,1,4 Emily Wilkins,1 Aaron Firestone,1 E. Carr Everbach,2
Jennifer C. Naylor,3 and Peter E. Simson3
1

Department of Psychology and 2Department of Engineering, Swarthmore College, Swarthmore, Pennsylvania 19081, USA;
Department of Psychology, Miami University, Oxford, Ohio 45056, USA

3

The effect of blockade of 5-HT1A receptors was investigated on (1) retention in a mildly aversive passive-avoidance
task, and (2) spontaneous single-unit activity of central nucleus of the amygdala (CeA) neurons, a brain site
implicated in modulation of retention. Systemic administration of the selective 5-HT1A antagonist NAN-190
immediately after training markedly—and dose-dependently—facilitated retention in the passive-avoidance task;
enhanced retention was time-dependent and was not attributable to variations in wattages of shock received by
animals. Systemic administration of NAN-190 had mixed effects on spontaneous single-unit activity of CeA neurons
recorded extracellularly in vivo; microiontophoretic application of 5-HT, in contrast, consistently and potently
suppressed CeA activity. The present findings—that 5-HT1A receptor blockade by NAN-190 (1) enhances retention in
the passive-avoidance task, and (2) does not consistently increase spontaneous neuronal activity of the CeA—provide
evidence that a serotonergic system tonically inhibits modulation of retention in the passive-avoidance task through
activation of the 5-HT1A receptor subtype at brain sites located outside the CeA.

Memory of emotional events is modulated by neuronal activity
in the amygdala (McGaugh et al. 1993, 1995). Strength of retention, in turn, is regulated by a variety of neurotransmitters, including norepinephrine (NE) and GABA, that influence the
amygdala. NE agonists infused directly into the amygdala immediately after training enhance retention (Liang et al. 1986, 1990;
Ferry and McGaugh 1999; Ferry et al. 1999); GABA agonists infused directly into the amygdala immediately after training impair retention (Castellano et al. 1989; Willensky et al. 2000).
There is evidence that serotonin, like GABA, inhibits amygdala activity and impairs retention. The evidence comes primarily from studies in which serotonergic agonists or antagonists
are injected directly into the amygdala after passive-avoidance
training. The evidence, however, is mixed: it is clear that activation of the serotonergic system via intra-amygdala injections of
the 5-HT1A agonist 8-OH-DPAT impairs retention (Liang 1999); it
is not clear that blockade of endogenous serotonin enhances retention. Specifically, retention is not enhanced by intra-amygdala injections of the 5-HT1A antagonist NAN-190 (Bernabeu et
al.1997; Bevilaqua et al. 1997a,b), and is only weakly enhanced
by intra-amygdala injections of the 5-HT1A antagonist
WAY-100635 (Liang 1999). Moreover, because cannulae implanted in the amygdala impair retention in and of themselves
through neuronal damage (Gold et al. 1975, 1978; Lennartz et al.
1996; Liang 1999; Schneider et al. 2002), the effect of intra-amygdala injections of 5-HT agonists and antagonists on retention in
the absence of neuronal damage remains an open question.
In the present study, we sought to determine whether a
4
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5-HT1A antagonist administered to unimpaired animals (i.e., in
the absence of cannulae-induced neuronal damage) enhances retention and, if so, whether the enhanced retention is associated
with increased firing rates of amygdala neurons. To accomplish
this, the effect of NAN-190, administered systemically, was determined on (1) retention in the passive-avoidance task, and (2)
spontaneous single-unit activity of central nucleus of the amygdala (CeA) neurons recorded electrophysiologically in vivo.
We recorded from CeA neurons because of previous findings
(Schneider et al. 2000; Simson et al. 2001) that systemically administered propranolol increased CeA activity and enhanced retention in the passive-avoidance task. Because propranolol has
both adrenergic and 5-HT1A antagonist action (Middlemiss 1984;
Oksenberg and Peroutka 1988; Kreiss and Lucki 1994), the present study—by utilizing the selective serotonergic antagonist
NAN-190—provided an opportunity to determine whether propranolol enhanced retention and increased amygdala activity, at
least in part, through 5-HT1A-blockade.
The passive-avoidance task was identical to the commonly
used one-trial passive-avoidance procedure (in which rats are
given a single foot-shock for stepping from a lighted to a dark
compartment), save for two modifications: (1) to investigate enhancing effects of drugs on retention (which requires weak retention in the absence of drugs), mildly aversive shock was used,
and (2) to monitor individual differences in reactions to the
mildly aversive shock, wattages actually received by animals were
recorded.
Animals’ reactions to shock are frequently monitored when
drugs are administered prior to passive-avoidance training in order to determine the extent to which drugs may affect retention
by altering the reactions to shock during training (e.g., Decker et
al. 1990; Lennartz et al. 1996). In the present study, although
drugs were administered after training, wattages received were
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nonetheless recorded owing to the low level of shock used to
investigate enhancement. That is, when delivering a low level of
shock—to which animals tend to show varied reactions—it could
not be assumed that animals in all groups would respond to
shock similarly. Consequently, to rule out that differences in
shock reactions—instead of drug effects—could account for differences in strength of retention between groups, wattages received were monitored.

RESULTS
When administered immediately after training, NAN-190 (1 mg/kg, i.p.)
enhances retention.
The effect of NAN-190 (0.5, 0.75, and 1.0 mg/kg, i.p.) and its
vehicle was determined on retention in the passive-avoidance
task. When administered systemically at a dose of 1.0 mg/kg
immediately after training, the 5-HT1A antagonist significantly
facilitated retention. As shown in Figure 1, step-through latencies
(STLs) (mean Ⳳ SEM) on the test day increased with increases in
the dose of NAN-190: compared to the 0.5 mg/kg dose (n = 10),
0.75 mg/kg dose (n = 10), or vehicle (n = 10), the 1.0 mg/kg dose
(n = 10) significantly increased STLs (1-tailed t = 2.07 [K = 4;
36df], P < .025). The mean STL on the test day for control animals receiving vehicle was 0.72 Ⳳ 0.30 min, whereas animals
receiving 0.5 mg/kg, 0.75 mg/kg, or 1.0 mg/kg of NAN-190
showed mean STLs of 1.05 Ⳳ .53 min, 1.72 Ⳳ .64 min, and
2.30 Ⳳ .61 min, respectively.

When administered in the absence of shock or 2 h or 6 h after training,
NAN-190 (1 mg/kg, i.p.) does not enhance retention.
That the ability of NAN-190 (1.0 mg/kg) to enhance retention
could not be attributed to aversive properties of the drug is evidenced by results from the no-shock control animals: in the absence of shock, the STLs (mean Ⳳ SEM) on the test day for noshock control animals receiving 1.0 mg/kg NAN-190
(0.13 Ⳳ 0.003 min; n = 5) did not differ significantly (t [onetailed] = 1.08 [8 df], P = .16) from STLs for no-shock control animals receiving vehicle (0.07 Ⳳ 0.002 min; n = 5).
The time-dependent effect of NAN-190 on retention is evi-

denced by the finding that STLs on the test day for animals receiving NAN-190 (1 mg/kg) 2 h after training (0.69 Ⳳ 0.20 min;
n = 8) did not differ significantly (one-tailed-t = 0.32 (14df),
P = .38) from STLs for animals receiving vehicle 2 h after training
(0.85 Ⳳ 0.07 min; n = 8). Similarly, STLs on the test day for animals receiving NAN-190 (1 mg/kg) 6 h after training (1.28 Ⳳ 0.39
min; n = 6) did not differ significantly (one-tailed-t = 0.94 [10df],
P = .18) from STLs for animals receiving vehicle 6 h after training
(0.49 Ⳳ 0.12 min; n = 6). This finding indicates that enhancement of retention produced by NAN 190 is indeed time-dependent and, therefore, most likely the result of blockade of 5-HT1A
receptors occurring during a critical period shortly after training
when strength of retention is regulated (inhibited) by serotonergic activity.

NAN-190’s ability to enhance retention cannot be attributed to
differences in wattage of shock received.
Wattage of shock received during training was generally highly
correlated with STLs during testing: as wattage received increased, STLs increased. In the vehicle control group, the correlation between wattage received and STLs was r = 0.64 (F = 5.6
[1,8 df], P = .04). In the NAN 0.5 group, NAN 0.75 group, and
NAN 1.0 group, the correlations between wattage received and
STLs were r = 0.23, r = 0.71, and r = 0.59, respectively. Given
these correlations between wattage received and STLs, the potential clearly existed for wattage to confound drug effects if different groups received—purely by chance—differing wattages: in
the present experiment, wattage received did not differ among
the vehicle and drug groups: F(3,36) = 1.00, P = .40.

In contrast to locally applied 5-HT, systemically administered NAN-190
does not consistently affect spontaneous single-unit activity of neurons in
the CeA.
All CeA neurons fired at a steady rate. NAN-190, when administered systemically at the dose that had significant effects on retention (1.0 mg/kg, i.p.), had mixed effects on spontaneous
single-unit activity of CeA neurons (Fig. 2) without altering the
steady pattern of firing: it increased (n = 2; Fig. 2A), decreased
(n = 4; Fig. 2B), and had no effect on (n = 3) CeA firing rates.
However, the failure of NAN-190 to consistently affect CeA neuronal activity was not due to the inability of serotonin to affect the CeA: when
applied microiontophoretically, serotonin
inhibited spontaneous activity of the CeA
in all neurons tested (n = 12; Figs. 3,4).

DISCUSSION

Figure 1 NAN-190 (1.0 mg/kg) enhanced retention in the passive-avoidance task. NAN-190 was
administered intraperitoneally immediately after training at 0.50 mg/kg (n = 10), 0.75 mg/kg (n = 10),
or 1.0 mg/kg (n = 10). Control animals received vehicle (n = 10). *P < .025.

The behavioral results show that blockade of 5-HT1A receptors immediately after training by systemic administration
of NAN-190 enhances retention in the
passive-avoidance task. Enhancement of
retention, as measured by STLs, increased as a function of the dosage of
NAN-190 administered, could not be attributed to aversive properties of the serotonergic antagonist (i.e., did not occur
in the absence of shock), and depended
on time of administration (occurring
with immediate, but not delayed, administration).
The electrophysiological results
show that blockade of 5-HT1A receptors
by systemic administration of NAN190 is not associated with consistent
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tered to anesthetized animals under precisely the same conditions as NAN-190
in the present study, does indeed consistently change CeA activity. Combined
with studies demonstrating that urethane does not produce qualitative
changes in neural activity—including responsiveness to pharmacological challenge—in a variety of brain sites compared to activity in awake, behaving animals (Givens and Breese 1990), it is
unlikely that the anesthetic per se prevented consistent changes in CeA activity from occurring.
It also might be argued that a
change in spontaneous activity by a
small subset of neurons in the CeA
(those showing an increase or decrease
in activity to NAN-190) rather than outside the CeA mediates NAN-190’s behavioral effects, but this, too, seems unlikely
in light of the neuropharmacological literature. For example, studies have
shown that NAN-190, infused directly
into the CeA at relatively low volumes
(Bernabeu et al. 1997; Bevilaqua et al.
1997a,b) fails to enhance retention,
whereas the 5HT1A-agonist 8-OH-DPAT
and the 5HT1A-antagonist WAY-100635,
infused directly into the amygdala at
relatively high volumes—volumes capable of spreading to areas outside the
amygdala (Myers 1966)—impair and enhance retention, respectively (Liang
1999). If 5HT1A-mediated modulation
indeed occurs at sites outside the CeA, as
our data suggest, infusion of relatively
small volumes of drug confined to the
CeA would not be expected to affect retention; infusion of relatively high volumes of drug that spread to areas outside
the CeA, in contrast, would be expected
Figure 2 Rate histograms of two representative CeA neurons demonstrating increases (Panel A) and
to affect retention. In this regard, neurodecreases (Panel B) in spontaneous firing rates to a single dose of NAN-190 (1 mg/kg, i.p.). After a
pharmacological studies suggest at least
baseline (predrug) period of spontaneous activity, NAN-190 was administered (as indicated by the two
tic marks extending below the histograms). The ordinate represents the number of action potentials
two brain sites outside the CeA involved
per 10-sec bin; the abscissa represents the number of 10-sec bins from the start of the recording. At
in serotonergic—and in particular
the same dose (1 mg/kg) that had significant effects on retention in the passive-avoidance task,
5-HT1A—modulation of retention: the
NAN-190 increased (n = 2; Panel A), decreased (n = 4; Panel B), and had no effect on (n = 3) sponbasolateral nucleus of the amygdala
taneous activity of single units of the CeA.
(Ferry and McGaugh 1999; Hatfield and
McGaugh 1999; Rainnie 1999) and the
changes in spontaneous CeA activity. This finding suggests that
hippocampus (Carli et al. 1995; Belcheva et al. 1997; Levkovitz
the increased retention produced by systemically administered
and Segal 1997; Liang et al. 1998).
NAN-190 is not associated with increased activity of the CeA.
That serotonin tonically inhibits retention through a
Taken together, the behavioral and electrophysiological results
5-HT1A-mediated modulatory system located outside the CeA
suggest that NAN-190 antagonizes a 5-HT1A-mediated moduladoes not rule out the possibility that serotonin also tonically
tory system located outside the CeA that tonically inhibits reteninhibits CeA firing rates through action on 5-HT1A receptors
tion.
within the CeA, particularly in light of the present findings that
Although the most likely explanation for results showing
CeA activity is potently suppressed by microiontophoretically
that NAN-190 is not associated with consistent changes in sponapplied 5-HT. For example, the effect of systemically administaneous CeA activity is that NAN-190 antagonizes a 5-HT1A-metered NAN-190 on spontaneous CeA activity could be the net
diated modulatory system located outside the CeA that tonically
result of competing actions of 5-HT1A-blockade both within the
inhibits retention, it is also conceivable that NAN-190 failed to
CeA (Kia et al. 1996) and on afferents projecting to the CeA
produce consistent changes in CeA activity because it was ad(Verge et al. 1986; Tork 1988; Sotelo et al. 1990; Riad et al. 2000).
ministered to anesthetized animals. This explanation is unlikely,
Blockade of inhibitory postsynaptic 5-HT1A receptors within the
however, because our laboratories (Simson et al. 2001) previously
CeA would be expected to increase, via disinhibition, CeA firing
showed that systemically administered propranolol, adminisrates (if these receptors were tonically activated by 5-HT); block-
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Figure 3 Current-response bar graph demonstrating inhibition of spontaneous activity in 12 CeA neurons by microiontophoretically applied 5-HT.
Bars represent mean percent change in firing rates from baseline (predrug) Ⳳ SEM at three ejection currents: 10 nA (left), 20 nA (middle), and 40 nA
(right). Each of the 12 neurons contributing to the current-response bars received multiple challenges with microiontophoretically applied 5-HT at each
of the three ejection currents (see Fig. 4, below).

ade of presynaptic 5-HT1A-autoreceptors (Kreiss and Lucki 1994)
on terminals projecting from the dorsal raphe to the CeA (Tork
1988; Sotelo et al. 1990) would be expected to inhibit CeA activity (by increasing release of serotonin onto CeA neurons). The
net effect of systemic NAN-190 administration on activity of a
single CeA neuron—increase, decrease, or no change—would

then depend on the relative contributions of the presynaptic
5-HT1A autoreceptors and postsynaptic 5-HT1A-receptors influencing the firing rate of the individual neuron.
One could test this model by restricting 5-HT1A blockade to
the CeA via local administration of NAN-190: the drug should
increase CeA firing rates because there would be no opposing

Figure 4 Rate histogram showing the current-response relationship of an individual CeA neuron to microiontophoretically applied 5-HT. The horizontal brackets above the histogram indicate the duration of current applied to the 5-HT containing pipette; numbers above the brackets indicate the
amount of ejection current.
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effect of blockade of inhibitory afferents influencing spontaneous CeA activity (assuming no 5-HT1A autoreceptors reside
within the CeA). Since intra-amygdala administration of NAN190 does not enhance retention (Bernabeu et al. 1997; Bevilaqua
et al. 1997a,b), such a finding would lend further support to a
dissociation between CeA activity and serotonergic modulation
of retention.
It appears, then, that a tonically active 5-HT1A-mediated
modulatory system inhibiting retention, when blocked, is not
associated with increased activity of the CeA. This contrasts with
previous reports that blockade of a tonically active ␤-adrenergic
modulatory system inhibiting retention is clearly associated with
increased activity of the CeA (Simson et al. 2001). Specifically,
using behavioral and electrophysiological procedures identical to
those in the present study, we reported that—like NAN-190—
systemic administration of the ␤-adrenergic receptor antagonist
propranolol enhances retention in the passive-avoidance task
(Schneider et al. 2000); unlike NAN-190, however, systemically
administered propranolol consistently increased CeA activity
(Simson et al. 2001).
Although propranolol has 5-HT1A antagonist properties
(Middlemiss 1984; Oksenberg and Peroutka 1988; Kreiss and
Lucki 1994), the present finding that NAN-190 did not increase
CeA firing rates discounts the possibility that propranolol increased CeA activity through 5-HT1A, rather than ␤-adrenergic,
blockade. This does not rule out the possibility, however, that
propranolol’s effect on retention, in contrast to its effect on CeA
activity, is mediated by 5-HT1A-blockade: propranolol’s ability to
enhance retention (Schneider et al. 2000), like NAN-190’s, may
depend on neither blockade of the ␤-adrenergic modulatory system nor increased activity of the CeA.
Delayed administration of NAN-190 failed to enhance retention in the passive-avoidance task, thus supporting memory
modulation as the means by which NAN-190 enhanced retention
when administered immediately after training. However, in addition to showing that systemically administered NAN-190 failed
to modulate retention when administered 2 h after training, the
present findings also indicate that the 5-HT1A antagonist failed to
enhance retention when administered 6 h after training. This
latter finding is of particular interest given that, when applied
locally in the hippocampus 6 h after training, NAN-190 enhances
retention (Bernabeu et al. 1997; Bevilaqua et al. 1997a,b). Of
course, blocking 5-HT1A receptors through systemic administration of NAN-190 is vastly different than doing so through local
administration. Indeed, that NAN-190 in our hands enhances
retention when administered immediately, but not 6 h, after
training may well be due to ambiguous signals when the hippocampus and amygdaloid sites modulating memory, by virtue of
systemic drug administration, are concurrently affected at a critical time period (i.e., immediately but not 6 h after training).
Other aspects of methodology differed between Bevilaqua et al.’s
study (1997a,b) and the present study, as well. For example,
although both studies used inhibitory-avoidance training,
Bevilaqua et al. used platform training and we used light-dark
training. Bevilaqua et al. necessarily cannulated animals—and we
as well as others have shown that cannulae-produced brain damage in and of itself affects retention in an inhibitory-avoidance
task (Gold et al. 1975, 1978; Lennartz et al. 1996; Liang 1999;
Schneider et al. 2002). Finally, wattage of shock actually received
by each animal was not monitored in the Bevilaqua et al. study;
differences among groups could have resulted in false positives
and/or false negatives.
In this regard, wattages of shock received by animals from a
constant-current shock source varied in the present study. These
variations in wattage received, presumably due to small variations in current or the resistance of the animal, were highly cor-
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related with retention in the passive-avoidance task. Although
not a factor in the present experiments, these results indicate
that, if by chance shock wattage were to differ among treatment
groups, animals might well show different strengths of retention
as a result of different reactions to shock, and not different reactions to treatment. To avoid such a potential confounding, studies using drugs and low levels of shock to investigate memoryrelated processes such as enhancement of retention should routinely monitor wattage received by animals, regardless of
whether drugs are administered prior to or after training.

MATERIALS AND METHODS
Behavioral Experiment: Retention of the
Passive-Avoidance Task
Experimental Design
The rats were randomly assigned to one of four groups: vehicle,
NAN 0.5 mg/kg, NAN 0.75 mg/kg, and NAN 1.0 mg/kg. They
were then trained and immediately given their designated treatment. Because the highest (1.0 mg/kg) but not the lower doses
(0.5, 0.75 mg/kg) of NAN-190 was found to increase retention,
two control experiments were conducted.
In one experiment, for the assessment of the time-dependent effects of the higher dose of NAN-190, animals received
vehicle or NAN-190 (1 mg/kg) 2 h or 6 h after the training trial.
Ordinarily, a 2-h delay group is sufficient to assess time-dependent effects (Schneider et al. 2000) but, because there is evidence
that NAN-190 injected locally into the hippocampus 6 h after
training enhances retention (Bernabeu et al. 1997; Bevilaqua et
al. 1997a,b), a 6-h group was included to determine whether
similar effects occur with systemically administered NAN-190.
In a second experiment, for the assessment of the potentially aversive effect of the higher dose of NAN-190 in and of
itself, animals received vehicle or NAN-190 (1 mg/kg) immediately after the training trial in the absence of shock (no-shock
control groups).

Animals
The subjects (n = 78) were male Long-Evans hooded rats (obtained from Harlan Sprague Dawley) weighing 250–325 g at the
start of the experiment. The rats were housed two to a cage with
access to food and water ad libitum. The colony room was maintained at 20°C and was illuminated on a 12-h light-dark cycle
(lights on at 9:00 a.m.). Each rat was handled daily for 15 sec and
was in the laboratory for at least 9 d, but not more than 18 d,
before the start of the experiment. All experiments were conducted between 10:00 a.m. and 3:00 p.m.

Apparatus
The rats were trained in a standard trough-shaped passive-avoidance apparatus that consisted of a small lighted compartment (20
⳯ 28 ⳯ 8 cm), illuminated by a 95-W bulb, connected to a larger
dark compartment (20 ⳯ 28 ⳯ 42 cm). A manually operated
sliding door separated the two compartments. The top of each
compartment was hinged, and the floor of each compartment
was made of stainless steel plates. A constant-current Lafayette
Master Shocker (Model 2400SS) was connected to the floor of the
large compartment. The apparatus was located in a quiet, dimly
illuminated room.

Drug Administration and Drug Doses
The rats were injected intraperitoneally with 1.0 mL of vehicle or
NAN-190 (Sigma Chemical). The vehicle was comprised of 25%
DMSO and 75% saline (0.9%). The doses of NAN-190 used were
0.5 mg/kg (NAN 0.5), 0.75 mg/kg (NAN 0.75), and 1.0 mg/kg
(NAN 1.0), dissolved in vehicle to a concentration of 0.5, 0.75, or
1.0 mg/mL, respectively. These doses of NAN-190 have been
shown to be behaviorally relevant (King et al. 1993; Hashimoto
et al. 1997).
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Training/Testing Procedure
The animals received a single training trial and a single test trial
the next day. On the training trial, all animals (except those in
the no-shock control groups) received shock (0.36 mA, 1-sec duration) for stepping from the lighted to dark compartment. STLs
on the training trial provided a measure of the animals’ inherent
(i.e., baseline) aversion to the dark compartment. STLs on the test
trial provided a measure of the animals’ learned aversion of the
dark compartment (i.e., a measure of retention). NAN-190 or vehicle was administered immediately, 2 h, or 6 h after the training
trial.
The training trial consisted of the following: Each rat was
placed in the lighted compartment facing away from the sliding
door. After 15 sec the door was raised, the animal was allowed to
step into the dark compartment, the door was lowered and shock
(if the animal was not in a no-shock control group) was delivered
to the floor of the compartment. The animal remained in the
dark compartment for 15 sec and was then removed and administered NAN-190 or vehicle. After each animal completed the
trial, the apparatus was cleaned.
The test trial was identical to the training trial except that
shock was omitted and drug was not administered. STLs on the
test trial served as the measure of retention, that is, as the STLs
increased, retention was taken to increase. If an STL reached 300
sec, the trial was terminated and the animal was retired from the
experiment. It should be noted that only four animals (one from
the NAN 0.5 group, two from the NAN 0.75 group, and one from
the NAN 1.0 group) reached the 300-sec cutoff.

Monitoring Wattage of Shock Actually Received
Preliminary observations indicated that even though shock current of 1-sec duration was set at 0.36 mA for all animals, there
were variations during training in the wattages received by animals. This raised the possibility that wattages received might differ, purely by chance, among the groups; differences in reactions
to shock resulting from differences in wattage received—instead
of, or in addition to, drug effects—might then account for differences in retention. Consequently, the wattage (time integral of
instantaneous current ⳯ voltage) received by each animal was
monitored via a custom-designed LabView computer program
and circuit board (PCI 6023E National Instruments).

Statistics
Data were analyzed with Dunnett t-tests (when comparing multiple treatment groups to a control group), Student’s t-test, or
one-way analyses of variance (ANOVAS) followed by protected-t
tests. P-values (two-tailed unless otherwise noted) of less than .05
were taken as significant.

Electrophysiological Experiment: Spontaneous
Single-Unit Activity of CeA Neurons
Preparation of Animals
Animals (n = 21) were male Long Evans hooded rats (Harlan
Sprague Dawley) weighing 250–400 grams. Stereotaxic surgery
was performed under urethane anesthesia (4.0 g/kg, i.p.). After
adjusting the incisor bar so that bregma and lambda suture landmarks lay in the same horizontal plane (skull flat), a burr hole
was made 2.1 mm posterior to bregma and 4.0 mm lateral to the
sagittal suture.

Single-Unit Recordings
When administering NAN-190 systemically, a single-barrel glass
recording electrode was produced by pulling a single-barrel micropipette (1.5 mm outside diameter; A&M Systems). The tip of
the pipette was then broken back to approximately 1.0 µ to obtain a recording impedance of 5–10 M⍀.
When administering 5-HT microiontophoretically, the
single-barrel recording electrode (above) was attached to a fourbarrel micropipette with epoxy cement such that the recording
electrode protruded 20 µ beyond the four-barrel pipette. Once
the epoxy had set, one of the barrels of the four-barrel micropi-

pette was filled with a solution of 5-HT dissolved in distilled
water to a concentration of 50 mM, and a second barrel (for the
current balance channel) was filled with 0.9% saline.
Whether administering drug systemically or iontophoretically, the recording electrode was filled with 0.9% NaCl saturated
with Sky Blue dye. The recording electrode (and four-barrel pipette assembly for iontophoresis) was then advanced into the
CeA via a hydraulic microdrive (Trent Wells). CeA neurons were
found at a depth of 6.5–8.0 mm below the dura at the coordinates
presented above. Action potentials from spontaneously firing,
single units were amplified by a high-impedance preamplifier
and a secondary amplifier (Fintronics), and then filtered and displayed on a Tektronix oscilloscope after being processed through
a window discriminator (Fintronics). Signals from the amplifier
also drive an audiomonitor. Individual spikes were isolated by
the window discriminator, then integrated over 10-sec periods by
a data collection program (Brainstorm Systems) and displayed in
real time on a computer monitor. Data were also stored on computer in real time. Interspike intervals were recorded to determine whether the pattern of neural firing remained consistent.
Neurons were isolated at random and were not preselected
based on firing rate, with one exception: a small percentage
(fewer than 10%) of neurons in the CeA displayed a strongly
rhythmic, bimodal bursting firing pattern. Neurons displaying
this rhythmically bursting firing pattern—a pattern described by
others and encountered similarly infrequently (Martina et al.
1999)—were not recorded from in the present study. Neurons
recorded from the CeA fired at a steady rate ranging between 4.4
and 13.6 spikes/sec, with a mean rate of 8.9 Ⳳ 0.84 spikes/sec.
Although difficult to encounter and isolate, waveforms were exceptionally homogenous and mostly positive-going, and of only
moderate amplitude. Only neurons meeting a criterion of at least
a 3:1 signal/noise (i.e., signal to background activity) ratio during
the baseline recording period were used. Only a single neuron
was recorded from each rat to avoid residual drug effects. Neurons showing signs of injury or marked irritability during the
recording procedure, as evidenced by marked alterations in waveform and/or amplitude, were not included in the study. If a neuron showed signs of injury after drug administration, the experiment was terminated, the rat was sacrificed, and the data were
discarded.
As neurons of the CeA were difficult to hold longer than
40–45 min (i.e., movement of the electrode and/or brain eventually resulted in smaller-than-optimal signal/noise ratios), recordings were limited to a 35-min postdrug recording period.

Drug Administration
Animals (n = 9) were injected intraperitoneally with vehicle or
1.0 mL of NAN-190 (Sigma Chemical). The vehicle was comprised of 25% DMSO and 75% saline (0.9%). NAN-190 was administered systemically at a dose of 1 mg/kg because these were
the dose and route utilized in the behavioral experiment demonstrating significant facilitation of retention.
Animals (n = 12) received microiontophoretic application of
50 mM 5-HT (Sigma Chemical) at ejection currents of 10 nA, 20
nA, and 40 nA.

Histology
Histological verification of electrode placement was obtained by
passing 5 µA of negative-going current through the recording
electrode for 5 min, thereby depositing a spot of Sky Blue at the
electrode tip. The brains were removed, frozen and cut in 20-µ
sections, and then analyzed for placement of the dye deposit.
Only animals from which recording electrodes were verified to be
located in the CeA were included in the study.
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